Evidence map›Paper›PMID 27669981›Full record

ArticleTrials2016

Erratum to: 'Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial'.

Thomas P Hellyer, Niall H Anderson, Jennie Parker, Paul Dark, Tina Van Den Broeck, Suveer Singh, Ronan McMullan, Ashley M Agus, Lydia M Emerson, Bronagh Blackwood and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Trials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Thomas P HellyerInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK. t.p.hellyer@ncl.ac.uk.
Niall H AndersonCentre for Population Health Sciences, University of Edinburgh, Medical School, Edinburgh, UK.
Jennie ParkerNewcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK.
Paul DarkInstitute of Inflammation and Repair, University of Manchester, Manchester Academic Health Sciences Centre & Intensive Care Unit, Salford Royal NHS Foundation Trust, Greater Manchester, UK.
Tina Van Den BroeckBecton Dickinson Biosciences, Erembodegem, Aalst, Belgium.
Suveer SinghIntensive Care Unit, Chelsea and Westminster Hospital, Imperial College London, London, UK.
Ronan McMullanDepartment of Medical Microbiology, Kelvin Building, The Royal Hospitals, Belfast, UK.
Ashley M AgusNorthern Ireland Clinical Trials Unit, Elliot Dynes Building, The Royal Hospitals, Belfast, UK.
Lydia M EmersonCentre for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Bronagh BlackwoodCentre for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Savita GossainPublic Health Laboratory, Heart of England NHS Foundation Trust, Birmingham, UK.
Tim S WalshMRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
Gavin D PerkinsUniversity of Warwick and Heart of England NHS Foundation Trust, Coventry, UK.
Andrew Conway MorrisDivision of Anaesthesia, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
Daniel F McAuleyCentre for Population Health Sciences, University of Edinburgh, Medical School, Edinburgh, UK.
A John SimpsonInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.

Funding

Medical Research Council G0901697
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27669981
PMCPMC5037580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.